Here is ILUMIEN™ OPTIS™ PCI Optimization™ System, a new technology designed to help physicians: stakes and opportunities.



The stakes here are the eye-opening perspective of the coronary arteries, this means, provide  physicians with a comprehensive disease assessment tool for treating patients
with coronary artery disease (CAD).
ILUMIEN OPTIS system helps physicians better understand which arteries should be treated and how best to treat them. It works by integrating both Fractional Flow Reserve (FFR) technology to measure blood flow blockage inside the coronary arteries and intravascular Optical Coherence Tomography (OCT) imaging technology.
Connectikpeople has discovered that, the OCT imaging technology provides a real-time, three-dimensional (3-D) reconstruction of the patient’s vessel, making it easier for physicians to visualize the area they are treating. The new system offers twice the resolution of the earlier generation, which allows for better microscopic examination of disease inside the artery to assist with stent placement.
The OCT technology in the new ILUMIEN OPTIS system uses the Dragonfly Duo Imaging Catheter to capture near-infrared light images and measures important vessel characteristics otherwise invisible or difficult to assess with older imaging technology.
The wireless PressureWire Aeris technology that is integrated into the platform measures pressure differences in blood flow within the coronary arteries leading to the heart, and determines the severity of any narrowings or blockages.
 The advancements in the ILUMIEN OPTIS system continue to build on St. Jude Medical’s leadership in providing innovative products that reduce health care costs and improve outcomes for patients battling coronary artery disease. This next-generation system is a scientific advancement that delivers critical information to physicians about the location and severity of disease within the coronary arteries, potentially resulting in better medical decision-making and overall cost-effective treatment,” said Frank J. Callaghan, president of the St. Jude Medical Cardiovascular and Ablation Technologies Division.

Popular Posts